home / stock / cvrx / cvrx news

CVRX News and Press, CVRx Inc. From 03/11/22

Stock Information
Company Name: CVRx Inc.
Stock Symbol: CVRX
Market: NASDAQ
Website: cvrx.com
Menu
CVRX CVRX Quote CVRX Short CVRX News CVRX Articles CVRX Message Board
Get CVRX Alerts

News, Short Squeeze, Breakout and More Instantly...
CVRX - CRSP, GILT and SDIG among after hour movers

Gainers: CRISPR Therapeutics AG (NASDAQ:CRSP) +26%. Micron Technology, Inc. (NASDAQ:MU) +15%. CVRx, Inc. (NASDAQ:CVRX) +11%. Academy Sports and Outdoors, Inc. (NASDAQ:ASO) +8%. KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) +6%. Losers: Gilat Satellite Networks Ltd. (NASDAQ:G...
CVRX - CVRx, Inc. (CVRX) CEO Nadim Yared on Q4 2021 Results - Earnings Call Transcript

CVRx, Inc. (CVRX) Q4 2021 Earnings Conference Call February 15, 2022, 05:30 PM ET Company Participants Nadim Yared – President & Chief Executive Officer Mike Vallie – Westwicke, ICR Company Jared Oasheim – Chief Financial Officer Conference Call Participants Robbie Ma...

CVRX - CVRx GAAP EPS of -$0.52 misses by $0.07, revenue of $3.7M misses by $0.07M

CVRx press release (NASDAQ:CVRX): Q4 GAAP EPS of -$0.52 misses by $0.07. Revenue of $3.7M (+76.2% Y/Y) misses by $0.07M. For further details see: CVRx GAAP EPS of -$0.52 misses by $0.07, revenue of $3.7M misses by $0.07M

CVRX - CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

MINNEAPOLIS, Feb. 15, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and oper...
CVRX - CVRx to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 15, 2022

MINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans ...

CVRX - CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results

MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced certain prelim...

CVRX - CVRx to Present at the 40th Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the manag...
CVRX - CVRx to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

MINNEAPOLIS, Nov. 16, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today a...

CVRX - CVRx, Inc. (CVRX) CEO Nadim Yared on Q3 2021 Results - Earnings Call Transcript

CVRx, Inc. (CVRX) Q3 2021 Earnings Conference Call November 04, 2021 05:30 PM ET Company Participants Mike Vallie - Westwicke, ICR Company Nadim Yared - President & Chief Executive Officer Jared Oasheim - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler...

CVRX - CVRx EPS beats by $0.08, beats on revenue

CVRx (NASDAQ:CVRX): Q3 GAAP EPS of -$0.30 beats by $0.08. Revenue of $3.4M (+243.4% Y/Y) beats by $0.12M. Press Release As of September 30, 2021, cash and cash equivalents were $170.9M compared to $47.1M as of June 30, 2021. Net cash used in operating and investing activities was $9.4M for th...
Previous 10 Next 10